ArticleJournal of medical cases2023
Catheter Ablation of Left Ventricular Summit Ectopies in Left Ventricular Noncompaction.
Article in Journal of medical cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricular noncompaction (LVNC) is a rare disorder and the true prevalence is largely unknown. Its clinical presentation is highly variable from being asymptomatic to the presence of heart failure, thromboembolic events, arrhythmias, and even risk of sudden cardiac death. A 37-year-old woman presented with frequent and symptomatic premature ventricular complexes (PVCs) and reduced left ventricular systolic function due to LVNC cardiomyopathy. The PVCs were refractory to medical therapy and the patient underwent successful ablation of the left ventricular summit PVCs. There was no recurrence of the PVCs at 6 months follow-up. This case report adds to the growing evidence of the efficacy and safety of performing radiofrequency ablation of ventricular arrhythmias (VAs) refractory to medical therapy in patients with LVNC. The different mechanisms of the VAs and therapeutic options are also reviewed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.